Scinai Immunotherapeutics Ltd. (SCNI)
1.72
+0.02
(+1.18%)
USD |
NASDAQ |
Sep 09, 16:00
1.72
0.00 (0.00%)
After-Hours: 19:07
Scinai Immunotherapeutics Shareholders Equity (Quarterly) : 11.73M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.73M |
| March 31, 2026 | 11.76M |
| December 31, 2025 | 8.103M |
| September 30, 2025 | |
| June 30, 2025 | 7.858M |
| March 31, 2025 | |
| December 31, 2024 | 9.977M |
| September 30, 2024 | 10.00M |
| June 30, 2024 | -7.284M |
| March 31, 2024 | -5.116M |
| December 31, 2023 | -4.569M |
| September 30, 2023 | -2.692M |
| June 30, 2023 | -7.112M |
| March 31, 2023 | -4.81M |
| December 31, 2022 | |
| September 30, 2022 | 2.631M |
| June 30, 2022 | 1.276M |
| March 31, 2022 | 5.067M |
| December 31, 2021 | 7.497M |
| September 30, 2021 | 1.298M |
| June 30, 2021 | 3.494M |
| March 31, 2021 | 6.239M |
| December 31, 2020 | -4.546M |
| September 30, 2020 | -0.5383M |
| June 30, 2020 | -17.89M |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | -18.83M |
| September 30, 2019 | -5.879M |
| June 30, 2019 | -20.33M |
| March 31, 2019 | -8.429M |
| December 31, 2018 | -8.354M |
| September 30, 2018 | 3.991M |
| June 30, 2018 | 4.565M |
| March 31, 2018 | 12.00M |
| December 31, 2017 | 16.20M |
| September 30, 2017 | 19.43M |
| June 30, 2017 | 6.015M |
| March 31, 2017 | 8.096M |
| December 31, 2016 | 6.656M |
| September 30, 2016 | 7.412M |
| June 30, 2016 | 7.771M |
| March 31, 2016 | 8.558M |
| December 31, 2015 | 8.621M |
| September 30, 2015 | 9.296M |
| June 30, 2015 | 9.526M |
| March 31, 2015 | 3.689M |
| December 31, 2014 | 4.262M |
| September 30, 2014 | 4.968M |
| June 30, 2014 | 5.844M |
| March 31, 2014 | 6.336M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd. | 88.73M |
| Pluri, Inc. | -18.60M |
| Evogene Ltd. | -3.29M |
| CollPlant Biotechnologies Ltd. | 4.886M |
| Regentis Biomaterials Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.17M |
| Total Liabilities (Quarterly) | 5.443M |
| Debt to Equity Ratio | 0.3052 |
| Current Ratio | 1.563 |
| Net Debt Paydown Yield | -49.73% |